Vitamin E supplementation reverses renal altered vascular reactivity in chronic bile duct-ligated rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 4, 2007, Pages

  Alcaraz, A ^a   Iyu D ^a   Atucha, N M ^a   Garcia Estan J ^a   Ortiz Ruiz, M C ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Cirrhosis; Kidney; Nitric oxide; Oxidative stress; Phospho extracellular regulated kinase1 2

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PHENYLEPHRINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; KIDNEY BLOOD VESSEL; LIVER CIRRHOSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASOCONSTRICTION; VASODILATATION; VITAMIN SUPPLEMENTATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; BILE DUCTS; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; KIDNEY; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITES; NITROPRUSSIDE; PERFUSION; PHENYLEPHRINE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VITAMIN E;

EID: 34147158753     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00309.2006     Document Type: Article

References (48)

1. Ara C, Karabulut AB, Kirimlioglu H, Coban S, Ugras M, Kirimliglu V, Yilmaz S. Protective effect of resveratrol against renal oxidative stress in cholestasis. Ren Fail 27: 435-440, 2005.
2. Atucha NM, Cegarra M, Ramírez A, Quesada T, García-Estañ J. Pressure diuresis and natriuresis in cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 265: G1045-G1049, 1993.
3. + channels. Clin Sci 99: 455-460, 2000.
4. Atucha NM, Quesada T, and García-Estañ J. Reduced renal papillary plasma flow in non-ascitic cirrhotic rats. Clin Sci 85: 139-145, 1993.
5. Atucha NM, Ramírez A, Quesada T, García-Estañ J. Effects of nitric oxide inhibition on the renal papillary blood flow response to saline-induced volume expansion in the rat. Clin Sci 86: 405-408, 1994.
6. Bauer PM, Buga GM, Ignarro LJ. Role of p42/p44 mitogen-activated-protein kinase and p21waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxide. Proc Natl Acad Sci USA 98: 12802-12807, 2001.
7. Beckman J, Koppenol W. Nitric oxide, superoxide, and peroxynitrite; the good the bad and the ugly. Am J Physiol Cell Physiol 271: C1424-C1437, 1996.
8. Benkusky NA, Lewis SJ, Kooy NW. Peroxynitrite-mediated attenuation of alpha and beta-adrenoceptor agonist-induced vascular responses in vivo. Eur J Pharmacol 364: 151-158, 1999.
9. Bomzon A, Huang YT. Vascular smooth muscle cell signaling in cirrhosis and portal hypertension. Pharmacol Ther 89: 255-272, 2001.
10. Bomzon A, Holt S, Moore K. Bile acids, oxidative stress, and renal function in biliary obstruction. Semin Nephrol 17: 549-562, 1997.
11. Bomzon A, Ljubuncic P. Oxidative stress and vascular smooth muscle cell function in liver disease. Pharmacol Ther 89: 295-308, 2001.
12. Cai H, Li Z, Davis ME, Kanner W, Harrison DG, Dudley SC Jr. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol 63: 325-331, 2003.
13. Chan CC, Chang CC, Huang HC, Wang SS, Lee FY, Chang FY, Lin HC, Tai CC, Lee SD. Effects of norepinephrine and acetylcholine on portal-systemic collaterals of common bile duct-ligated cirrhotic rat. J Gastroenterol Hepatol 20: 1867-1872, 2005.
14. Cioffi WG, DeMeules JE, Kahng KU, Wait RB. Renal vascular reactivity in jaundice. Surgery 100: 356-362, 1986.
15. Criado M, Flores O, Ortiz MC, Hidalgo F, Rodríguez-López AM, Eleno N, Atucha NM, Sánchez-Rodríguez A, Arévalo M, García-Estañ J, López-Novoa JM. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: role of inducible nitric oxide synthase activation. Hepatology 26: 268-276, 1997.
16. Cruz A, Padillo FJ, Túnez I, Muñoz C, Granados J, Pera-Madrazo C, Montilla P. Melatonin protects against renal oxidative stress after obstructive jaundice in rats. Eur J Pharmacol 425: 135-139, 2001.
17. Fernando B, Marley R, Holt S, Anand R, Harry D, Sanderson P, Smith R, Hamilton G, Moore K. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 28: 689-694, 1998.
18. Fortuno A, Jose GS, Moreno MU, Díez J, Zalba G. Oxidative stress and vascular remodelling. Exp Physiol 90: 457-462, 2005.
19. García-Estañ J, Atucha NM, Groszman RJ. Renal response to methoxamine in portal hypertensive rats: role of prostaglandins and nitric oxide. J Hepatol 25: 206-211, 1996.
20. García-Estañ J, Ortiz MC, O'valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM. Effects of angiotensin-converting- enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide deficiency-induced hypertension in rats. Clin Sci 110: 227-233, 2006.
21. Ginés P, Guevara M, Arroyo V, Rodés J. Hepatorenal syndrome. Lancet 362: 1819-1827, 2003.
22. Griendling KK, Sorescu D, Lassegue B, and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20: 2175-2183, 2000.
23. S6k*. J Biol Chem 275: 11389-11396, 2000.
24. Heneghan MA, Harrison PM. Pathogenesis of ascites in cirrhosis and portal hypertension. Med Sci Monit 6: 807-816, 2000.
25. Holt S, Goodier D, Marley R, Patch D, Burroughs A, Fernando B, Harry D, Moore K. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet 353: 294-295, 1999.
26. Hosokawa H, Aiuchi S, Kambe T, Hagiwara Y, Kubo T. Mechanical stretch-induced mitogen-activated protein kinase activation is mediated via angiotensin and endothelin systems in vascular smooth muscle cells. Biol Pharm Bull 25: 1588-1592, 2002.
27. Inan M, Sayek I, Tel BC, Sahin-Erdemli I. Role of endotoxin and nitric oxide in the pathogenesis of renal failure in obstructive jaundice. Br J Surg 84: 943-947, 1997.
28. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 87: 179-183, 2000.
29. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 20: 443-448, 1996.
30. Korkmaz B, Ozveren E, Buharalioglu CK, Tunctan B. Extracellular signal-regulated kinase (ERK1/2) contributes to endotoxin-induced hyporeactivity via nitric oxide and prostacyclin production in rat aorta. Pharmacology 78: 123-128, 2006.
31. Ljubuncic P, Tanne Z, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 47: 710-716, 2000.
32. Marley R, Holt S, Fernando B, Harry D, Anand R, Goodier D, Davies S, Moore K. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology 29: 1358-1363, 1999.
33. Martínez-Prieto C, Ortiz MC, Fortepiani LA, Ruiz-Maciá J, Atucha NM, and García-Estañ J. Haemodynamic and renal evolution of the bile duct-ligated rat. Clin Sci 98: 611-617, 2000.
34. Moore K. Isoprostanes and the liver. Chem Phys Lipids 128: 125-133, 2004.
35. Moore K, Roberts LJ, 2nd. Measurement of lipid peroxidation. Free Radic Res 28: 659-671, 1998.
36. Morrow JD, Moore KP, Awad JA, Ravenscraft MD, Marini G, Badr KF, Williams R, Roberts LJ 2nd. Marked overproduction of noncyclooxygenase derived prostanoids (F2-isoprostanes) in the hepatorenal syndrome. J Lipid Mediat Cell Signal 6: 417-420, 1993.
37. Nanji AA, Khwaja S, Tahan SR, Sadrzadeh SM. Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease. J Pharmacol Exp Ther 269: 1280-1285, 1994.
38. Orellana M, Rodrigo R, Thielemann L, Guajardo V. Bile duct ligation and oxidative stress in the rat: effects in liver and kidney. Comp Biochem Physiol C 126: 105-111, 2000.
39. Ortiz MC, Fortepiani LA, Martínez C, Atucha NM, García-Estañ J. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium. Clin Sci 91: 733-738, 1996.
40. Ortiz MC, Fortepiani LA, Martínez C, Atucha NM, García-Estañ J. Renal and pressor effects of aminoguanidine in cirrhotic rats with ascites. J Am Soc Nephrol 7: 2694-2699, 1996.
41. Ortiz MC, Manriquez MC, Nath KA, Lager DJ, Romero JC, Juncos LA. Vitamin E prevents renal dysfunction induced by experimental chronic bile duct ligation. Kidney Int 64: 950-961, 2003.
42. Pateron D, Oberti F, Lefilliatre P, Veal N, Tazi KA, Sogni P, Poirel O, Heller J, Moreau R, Cales P, Lebrec D. Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis. Clin Sci 97: 313-318, 1999.
43. Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and STAT1 alpha. J Biol Chem 271: 1111-1117, 1996.
44. Touyz RM, Deschepper C, Park JB, He G, Chen X, Neves MF, Virdis A, Schiffrin EL. Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats. J Hypertens 20: 1127-1134, 2002.
45. Weigert AL, Martin PY, Schrier RW. Vascular hyporesponsiveness in cirrhotic rats: role of different nitric oxide synthase isoforms. Kidney Int 61: S41-S44, 1997.
46. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 35: 478-491, 2002.
47. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 97: 508-514, 1996.
48. Yura T, Fukunaga M, Khan R, Nassar GN, Badr KF, Montero A. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int 56: 471-478, 1999.